Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

NCT06113705 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DIAGNOSTIC_TEST: 18F-GE-180 PET
DIAGNOSTIC_TEST: Advanced MRI
OTHER: Collection of hematopoietic stem cells
OTHER: Blood withdrawal
OTHER: Collection of Cancer Stem Cells

Sponsor

Istituto Clinico Humanitas

Collaborators

[object Object]